drugset
drugset / Trial / NCT01767272

Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers

NCT01767272 ↗

Completed 25 enrolled Damanhour University
RandomizedCrossoverOpen-label

Summary

The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after oral administration.

Timeline

Start
2012-12
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 60 mg Oral
Subject Fexofenadine Unknown 120 mg Oral
Subject Fexofenadine Unknown 180 mg Oral
Subject Fexofenadine Unknown 240 mg Oral
Subject Fexofenadine Unknown 360 mg Oral

Indications

No indication recorded.